Cardiac Biotech Solutions, Inc. (OTCID: CBSC) (“CBSC” or the “Company”), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products, today provided an update on ...
According to Cardiac Event Monitor Markets: Market Shares, Strategies, and Forecasts, 2017 to 2023 report, growth is based on implementation of devices that measure cardiac function over a period of a ...
LAS VEGAS, NV / ACCESS Newswire / February 25, 2025 / CB Scientific, Inc. (CBSC) (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac ...
ESCONDIDO, CA / ACCESSWIRE / September 6, 2022 / CB Scientific. Inc.(OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring ...
ESCONDIDO, CA / ACCESSWIRE / May 24, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products ...
PaceMate delivers a patient management solution that addresses the full cardiac device care continuum. SARASOTA, Fla., May 19, 2023 /PRNewswire/ -- PaceMate ® announced today its collaboration with ...
The "Cardiac Monitoring Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Cardiac Monitoring Market was valued at USD 8.24 billion in 2024, and is ...
The peer-reviewed manuscript, titled “Comparative Effectiveness and Healthcare Utilization for Ambulatory Cardiac Monitoring (ACM) Strategies in Medicare Beneficiaries,” reveals that the Zio long-term ...
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...